Grail Raises $390M In Series D Financing To Advance Blood Cancer Test
Liquid biopsy company Grail raised $390m in a fourth round of financing, bringing the total funding to $1.9bn.
Liquid biopsy company Grail raised $390m in a fourth round of financing, bringing the total funding to $1.9bn.